JP2021521262A5 - - Google Patents
Info
- Publication number
- JP2021521262A5 JP2021521262A5 JP2020566867A JP2020566867A JP2021521262A5 JP 2021521262 A5 JP2021521262 A5 JP 2021521262A5 JP 2020566867 A JP2020566867 A JP 2020566867A JP 2020566867 A JP2020566867 A JP 2020566867A JP 2021521262 A5 JP2021521262 A5 JP 2021521262A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cells
- formula
- graft
- use according
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862632733P | 2018-02-20 | 2018-02-20 | |
| US62/632,733 | 2018-02-20 | ||
| PCT/CA2019/050208 WO2019161494A1 (en) | 2018-02-20 | 2019-02-20 | Expansion of nk and dc cells in vivo mediating immune response |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021521262A JP2021521262A (ja) | 2021-08-26 |
| JPWO2019161494A5 JPWO2019161494A5 (https=) | 2022-02-24 |
| JP2021521262A5 true JP2021521262A5 (https=) | 2022-02-24 |
| JP7467358B2 JP7467358B2 (ja) | 2024-04-15 |
Family
ID=67687479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566867A Active JP7467358B2 (ja) | 2018-02-20 | 2019-02-20 | 免疫応答を媒介するｉｎ ｖｉｖｏでのＮＫ細胞およびＤＣ細胞の拡大 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12011460B2 (https=) |
| EP (1) | EP3755355A4 (https=) |
| JP (1) | JP7467358B2 (https=) |
| CN (1) | CN112135618A (https=) |
| CA (1) | CA3091865A1 (https=) |
| WO (1) | WO2019161494A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109212187B (zh) * | 2018-09-06 | 2022-01-11 | 东华大学 | 一种检测多环芳烃的类酶联免疫试剂盒及其应用 |
| CN112851678B (zh) * | 2019-11-28 | 2022-04-19 | 广东医科大学 | 2，4，7-三取代嘧啶并吲哚化合物抗肿瘤转移作用 |
| CN112851679B (zh) * | 2019-11-28 | 2022-03-25 | 广东医科大学 | 2，4，7-三取代嘧啶并吲哚化合物抗肿瘤作用 |
| AU2020409437A1 (en) * | 2019-12-18 | 2022-07-14 | Universite De Montreal | Modulators of Cullin 3 adaptor KBTBD4 as anti-cancer compounds |
| CN113350356B (zh) * | 2021-05-26 | 2022-12-27 | 广东湛江海洋医药研究院 | 2,4,7-三取代嘧啶并吲哚化合物抗肿瘤耐药作用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858782A (en) * | 1995-11-13 | 1999-01-12 | Regents Of The University Of Michigan | Functional human hematopoietic cells |
| EP1442039A1 (en) | 2001-10-31 | 2004-08-04 | Bayer HealthCare AG | Pyrimido (4,5-b) indole derivatives |
| US20090099165A1 (en) | 2003-10-14 | 2009-04-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein Kinase Inhibitors |
| US20090029982A1 (en) | 2005-04-28 | 2009-01-29 | Supergen, Inc. | Protein kinase inhibitors |
| KR20080105555A (ko) | 2007-05-31 | 2008-12-04 | 인하대학교 산학협력단 | 중간엽 골수세포를 이용한 이식편대숙주질환 치료제 및치료방법 |
| EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| WO2008055233A1 (en) | 2006-10-31 | 2008-05-08 | Supergen, Inc. | Protein kinase inhibitors |
| EP2121692B1 (en) | 2006-12-22 | 2013-04-10 | Incyte Corporation | Substituted heterocycles as janus kinase inhibitors |
| EP2170886A1 (en) | 2007-07-02 | 2010-04-07 | Cancer Research Technology Limited | 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors |
| US7960400B2 (en) | 2007-08-27 | 2011-06-14 | Duquesne University Of The Holy Ghost | Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| WO2011056739A1 (en) | 2009-11-03 | 2011-05-12 | Glaxosmithkline Llc | Compounds and methods |
| AU2015271985A1 (en) * | 2010-07-13 | 2016-01-21 | Anthrogenesis Corporation | Methods of generating natural killer cells |
| CA2858069C (en) * | 2011-12-08 | 2020-02-11 | Novartis Ag | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells |
| PT2807165T (pt) | 2012-01-27 | 2019-07-12 | Univ Montreal | Derivados de pirimido[4,5-b]indole e sua utilização na expansão de células estaminais hematopoiéticas |
| JP6460991B2 (ja) | 2012-09-12 | 2019-01-30 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 抗菌剤として使用するための三環式ジャイレース阻害剤 |
| CA2946446C (en) | 2014-04-22 | 2020-11-03 | Universite De Montreal | Pyrido-pyrrolo-pyrimidine and pyrido-indole compounds, pharmaceutical compositions containing same and their use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells |
| NZ733213A (en) | 2014-12-31 | 2022-10-28 | Celularity Inc | Natural killer cells and uses thereof |
| MY201637A (en) * | 2015-10-15 | 2024-03-06 | Celularity Inc | Natural killer cells and ilc3 cells and uses thereof |
| WO2017120597A1 (en) | 2016-01-07 | 2017-07-13 | Ripple Foods, Pbc | Product analogs or components of such analogs and processes for making same |
| CA3024273A1 (en) | 2016-06-01 | 2017-12-07 | Universite De Montreal | Selection of human hematopoetic stem cells using epcr |
-
2019
- 2019-02-20 US US16/970,473 patent/US12011460B2/en active Active
- 2019-02-20 CA CA3091865A patent/CA3091865A1/en active Pending
- 2019-02-20 JP JP2020566867A patent/JP7467358B2/ja active Active
- 2019-02-20 WO PCT/CA2019/050208 patent/WO2019161494A1/en not_active Ceased
- 2019-02-20 CN CN201980022329.9A patent/CN112135618A/zh active Pending
- 2019-02-20 EP EP19757891.7A patent/EP3755355A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021521262A5 (https=) | ||
| US20200283727A1 (en) | Methods of expanding and assessing b cells and using expanded b cells to treat disease | |
| Ueda et al. | IL-1R type I-dependent hemopoietic stem cell proliferation is necessary for inflammatory granulopoiesis and reactive neutrophilia | |
| US6165785A (en) | Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications | |
| JP2015504902A5 (https=) | ||
| RU2472509C2 (ru) | Способ лечения артрита | |
| EP2836214B1 (en) | Bruton's tyrosine kinase inhibitors for hematopoietic mobilization | |
| WO2015057992A1 (en) | Btk inhibitors for hematopoietic mobilization | |
| JP2017513897A5 (https=) | ||
| JP7467358B2 (ja) | 免疫応答を媒介するｉｎ ｖｉｖｏでのＮＫ細胞およびＤＣ細胞の拡大 | |
| JP2014500296A5 (https=) | ||
| US20220168393A1 (en) | Il-12 compositions and methods of use in hematopoietic recovery | |
| JP2021512903A5 (https=) | ||
| Roeleveld et al. | The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders | |
| JPWO2019161494A5 (https=) | ||
| JPH11509845A (ja) | 造血多分化性細胞移植のための放射線または放射線類似作用化学療法の減少方法 | |
| Gazitt et al. | Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors | |
| WO2021095700A1 (ja) | 樹状細胞分化誘導培地、及び樹状細胞集団の製造方法 | |
| JP2008543822A5 (https=) | ||
| Pashkina et al. | CD5 Expression by Innate Lymphoid Cells Type 2 in Multiple Myeloma Before and After Hematopoietic Stem Cell Transplantation | |
| Sedlmayr et al. | Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia | |
| HK40106739A (zh) | 与阿扎胞苷联合用於治疗骨髓增生异常综合征的维奈托克给药方案 | |
| EP4572775A2 (en) | Alleviating graft versus host disease using engineered inkt cells | |
| RU2023136077A (ru) | Ингибитор мутанта idh и его применение | |
| Klamer et al. | Strategies to Improve Immune |